Machine perfusion for livers from donation after circulatory death
Part of Digestive system clinical trials.
This study tests a new way to preserve donated livers (called machine perfusion) after they are recovered from donors who died from circulatory causes. It aims to see if this method helps the liver work better before transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The donated liver must come from a donor who is 18 years or older, with a body mass index (BMI) under 35, and whose heart stopped for less than 30 minutes before the organ was preserved.
- You must be 18 or older and listed on the standard (non-urgent) liver transplant waiting list.
- This must be your first liver transplant.
- You cannot have conditions that make surgery very risky, like major blood clots in the liver's blood vessels or previous complex stomach surgery.
- You and the donor family must give permission for the donated liver to be used in this research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information about how livers do after transplantation when they've been preserved using machine perfusion—a technique that keeps donor livers in better condition before surgery. Researchers want to understand which preservation methods work best to improve transplant success across Europe.
This trial tests whether using a machine to keep donated livers healthy (normothermic machine perfusion) can allow more people to receive a transplant sooner. It is for patients who are already on the waiting list for a liver and have a moderately severe MELD score (25 or less).
This trial tests whether adding a hormone called secretin to a machine that preserves donated livers outside the body can improve liver quality and transplant outcomes. You may qualify if you're an adult receiving a standard deceased-donor liver transplant that needs special preservation techniques.
This trial tests a new way to preserve donated livers with a machine called eXVIVO before transplant. It is for adults receiving their first liver transplant and aims to see if this preservation method improves outcomes.
This trial tests a special preservation machine that keeps donor livers cold and functioning during transport before transplant. The goal is to improve how well donated livers work after transplantation and reduce complications.
This trial tests if a machine that pumps warm oxygenated blood through livers that were considered unsuitable for transplant can help doctors decide if they are actually safe to transplant. If so, it could increase the number of available livers for people waiting for a first liver transplant.
Hear when a new Liver Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.